GENOME ANNOUNCEMENT {#s1}
===================

Neisseria gonorrhoeae is the etiological agent of the sexually transmitted disease gonorrhea, and it poses a public health threat due to the emergence of multidrug-resistant strains ([@B1][@B2][@B4]). Whole-genome sequencing is considered a powerful strategy to elucidate chains of transmission ([@B5]). Here, we announce the draft genome sequences of 13 epidemiologically linked N. gonorrhoeae isolates.

Two vaginal swabs, taken from a 3-year-old girl on 10 January 2018, and her rectal swab, gained on 13 January 2018, yielded N. gonorrhoeae colonies on Chocolat PolyViteX VCAT3 agar plates (bioMérieux, Marcy-l'Étoile, France). A 46-year-old male household member was sampled on 13 January 2018, and N. gonorrhoeae colonies grew from a rectal swab. Eight single colonies from the child and five from the adult were further analyzed.

For each isolate, antimicrobial susceptibility was determined according to the EUCAST recommendations for gonococci ([@B6]). All 13 isolates showed resistance to penicillin G (median MIC, 6 µg/ml; range, 1.5 to 32 µg/ml), tetracycline (median MIC, 24 µg/ml; range, 24 to 64 µg/ml), and ciprofloxacin (median MIC, 0.75 µg/ml; range, 0.5 to 1.5 µg/ml), but were susceptible to ceftriaxone, cefixime, and azithromycin.

Genomic DNA isolation, whole-genome sequencing, assembly, and contig filtering were performed as described previously ([@B7]). Paired-end sequencing (2 × 300 bp) generated 348,172 to 847,328 reads, with a mean coverage of 41- to 89-fold. The NCBI Prokaryotic Genome Automatic Annotation Pipeline identified 2,654 to 2,720 genes, 2,604 to 2,664 coding sequences, 273 to 305 pseudogenes, 3 to 6 rRNA genes, and 47 to 51 tRNA genes.

Antimicrobial resistance genes were identified using the Comprehensive Antibiotic Resistance Database (CARD) ([@B8]). All 13 isolates had *gyrA*, N. meningitidis PBP2 and *rpsJ,* and the efflux genes *farA*, *farB*, *macA*, *macB*, *mtrC*, *mtrD*, and *mtrR*. In addition, *bla*~TEM-1~ was detected in three child and three household member isolates. Three isolates from the child and one from the household member carried *bla*~TEM-90~. One child isolate had *bla*~TEM-150~, and another one carried *bla*~TEM-150~ plus the efflux gene *patA*.

All 13 isolates belonged to multilocus sequence type (MLST) 1588 (ST1588). An *ad hoc* core genome MLST (cgMLST) scheme comprising 1,524 targets was established using strain MS11 (ATCC BAA-1833) as a reference. Child isolates differed by zero to three alleles and household member isolates by zero to one alleles; the maximum interindividual variability of the isolates was five allelic differences. In the course of comparison with the Austrian Agency for Health and Food Safety (AGES) N. gonorrhoeae whole-genome database (currently covering 452 isolates from the years 2014 to 2018), all but one isolate differed by at least 303 alleles. An isolate gained in 2016 (strain 980016-16) from a urethral swab of an epidemiologically unrelated 32-year-old male patient, registered in the same Austrian province as the two described case patients, showed a six-allele difference. From these results, we propose a complex-type threshold of a maximum of five allelic differences for direct transmission events of N. gonorrhoeae. Our findings underline the considerable potential of whole-genome sequencing (WGS) to document chains of transmission.

Accession number(s). {#s1.1}
--------------------

This whole-genome shotgun project has been deposited at DDBJ/EMBL/GenBank under the accession numbers shown in [Table 1](#tab1){ref-type="table"}. The versions described in this paper are the first versions.

###### 

Fourteen N. gonorrhoeae isolates included in BioProject PRJNA433931

  Strain      GenBank accession no.                                               No. of contigs   Total length (bp)
  ----------- ------------------------------------------------------------------- ---------------- -------------------
  980035-18   [PTPT00000000](https://www.ncbi.nlm.nih.gov/nuccore/PTPT00000000)   173              2,234,140
  980036-18   [PTPS00000000](https://www.ncbi.nlm.nih.gov/nuccore/PTPS00000000)   155              2,227,585
  980037-18   [PTPR00000000](https://www.ncbi.nlm.nih.gov/nuccore/PTPR00000000)   203              2,214,439
  980038-18   [PTPQ00000000](https://www.ncbi.nlm.nih.gov/nuccore/PTPQ00000000)   193              2,239,226
  980039-18   [PTPP00000000](https://www.ncbi.nlm.nih.gov/nuccore/PTPP00000000)   164              2,214,439
  980040-18   [PTPO00000000](https://www.ncbi.nlm.nih.gov/nuccore/PTPO00000000)   191              2,232,201
  980041-18   [PTPN00000000](https://www.ncbi.nlm.nih.gov/nuccore/PTPN00000000)   156              2,226,960
  980042-18   [PTPM00000000](https://www.ncbi.nlm.nih.gov/nuccore/PTPM00000000)   168              2,223,307
  980043-18   [PTPL00000000](https://www.ncbi.nlm.nih.gov/nuccore/PTPL00000000)   160              2,217,312
  980044-18   [PTPK00000000](https://www.ncbi.nlm.nih.gov/nuccore/PTPK00000000)   137              2,214,035
  980045-18   [PTPJ00000000](https://www.ncbi.nlm.nih.gov/nuccore/PTPJ00000000)   141              2,210,712
  980046-18   [PTPI00000000](https://www.ncbi.nlm.nih.gov/nuccore/PTPI00000000)   140              2,217,914
  980047-18   [PTPH00000000](https://www.ncbi.nlm.nih.gov/nuccore/PTPH00000000)   199              2,209,742
  980016-16   [PTPG00000000](https://www.ncbi.nlm.nih.gov/nuccore/PTPG00000000)   178              2,233,553
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